172 related articles for article (PubMed ID: 32577702)
1. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
medRxiv; 2020 Jun; ():. PubMed ID: 32577702
[TBL] [Abstract][Full Text] [Related]
2. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
J Hematol Oncol; 2020 Jul; 13(1):94. PubMed ID: 32664919
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
[TBL] [Abstract][Full Text] [Related]
5. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.
Chilimuri S; Sun H; Alemam A; Mantri N; Shehi E; Tejada J; Yugay A; Nayudu SK
West J Emerg Med; 2020 Jul; 21(4):779-784. PubMed ID: 32726241
[TBL] [Abstract][Full Text] [Related]
7. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
8. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.
Zachariah P; Johnson CL; Halabi KC; Ahn D; Sen AI; Fischer A; Banker SL; Giordano M; Manice CS; Diamond R; Sewell TB; Schweickert AJ; Babineau JR; Carter RC; Fenster DB; Orange JS; McCann TA; Kernie SG; Saiman L;
JAMA Pediatr; 2020 Oct; 174(10):e202430. PubMed ID: 32492092
[TBL] [Abstract][Full Text] [Related]
10. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
11. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
12. Chronic Hemodialysis Patients Hospitalized with COVID-19: Short-term Outcomes in the Bronx, New York.
Fisher M; Yunes M; Mokrzycki MH; Golestaneh L; Alahiri E; Coco M
Kidney360; 2020 Aug; 1(8):755-762. PubMed ID: 35372963
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans.
Ashktorab H; Pizuorno A; Adeleye F; Laiyemo A; Dalivand MM; Aduli F; Sherif ZA; Oskrochi G; Angesom K; Oppong-Twene P; Challa SR; Okorie N; Moon ES; Romos E; Jones-Wonni B; Kone AM; Rankine S; Thrift C; Scholes D; Ekwunazu C; Banson A; Mitchell B; Maskalo G; Ross J; Curtis J; Kim R; Gilliard C; Ahuja G; Mathew J; Gavin W; Kara A; Hache-Marliere M; Palaiodimos L; Mani VR; Kalabin A; Gayam VR; Garlapati PR; Miller J; Chirumamilla LG; Jackson F; Carethers JM; Kamangar F; Brim H
BMC Infect Dis; 2022 Jun; 22(1):552. PubMed ID: 35715729
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation of pediatric patients with symptomatic SARS-CoV-2 infection during the first months of the COVID-19 pandemic in a single center in Mexico City.
Aragón-Nogales R; Zurita-Cruz J; Vázquez-Rosales G; Arias-Flores R; Gómez-González C; Montaño-Luna V; Sámano-Aviña M; Pacheco-Rosas D; Flores-Ruiz E; Villasís-Keever M; Miranda-Novales G
Front Pediatr; 2022; 10():912784. PubMed ID: 35967584
[TBL] [Abstract][Full Text] [Related]
15. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Antibody Response among Women Infected during Pregnancy.
Buckley A; Mills A; Paul K; Raymond S; Mendu DR; DeBolt C; Rosenberg M; Wajnberg A; Szeto L; Cochrane E; Vieira L; Berkin J; Ferrera L; Stone J; Bianco A
Am J Perinatol; 2022 May; 39(7):707-713. PubMed ID: 34768307
[TBL] [Abstract][Full Text] [Related]
20. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
